Invesco’s Lyell Immunopharma LYEL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Sell |
12,809
-366,071
| -97% | -$3.24M | ﹤0.01% | 3635 |
|
|
2025
Q1 | $204K | Sell |
378,880
-28,325
| -7% | -$15.2K | ﹤0.01% | 3493 |
|
|
2024
Q4 | $261K | Buy |
407,205
+1,256
| +0.3% | +$804 | ﹤0.01% | 3441 |
|
|
2024
Q3 | $560K | Sell |
405,949
-916
| -0.2% | -$1.26K | ﹤0.01% | 3171 |
|
|
2024
Q2 | $590K | Sell |
406,865
-2,541
| -0.6% | -$3.68K | ﹤0.01% | 3195 |
|
|
2024
Q1 | $913K | Buy |
409,406
+98,297
| +32% | +$219K | ﹤0.01% | 3025 |
|
|
2023
Q4 | $604K | Buy |
311,109
+18,397
| +6% | +$35.7K | ﹤0.01% | 3113 |
|
|
2023
Q3 | $430K | Buy |
292,712
+2,051
| +0.7% | +$3.02K | ﹤0.01% | 3258 |
|
|
2023
Q2 | $924K | Buy |
290,661
+1,475
| +0.5% | +$4.69K | ﹤0.01% | 2925 |
|
|
2023
Q1 | $682K | Buy |
289,186
+233,514
| +419% | +$551K | ﹤0.01% | 3088 |
|
|
2022
Q4 | $193K | Sell |
55,672
-255,324
| -82% | -$886K | ﹤0.01% | 3671 |
|
|
2022
Q3 | $2.28M | Buy |
310,996
+254,876
| +454% | +$1.87M | ﹤0.01% | 2572 |
|
|
2022
Q2 | $366K | Sell |
56,120
-2,564
| -4% | -$16.7K | ﹤0.01% | 3464 |
|
|
2022
Q1 | $296K | Buy |
58,684
+47,145
| +409% | +$238K | ﹤0.01% | 3604 |
|
|
2021
Q4 | $89K | Buy |
+11,539
| New | +$89K | ﹤0.01% | 3880 |
|